RP11-362K2.2:RP11-767I20.1 Genetic Variation Is Associated with Post-Reperfusion Therapy Parenchymal Hematoma. A GWAS Meta-Analysis
Authors:
- Elena MuiñoEMElena Muiño
- Jara Cárcel-MárquezJCJara Cárcel-Márquez
- Caty CarreraCCCaty Carrera
- Laia Llucià-CarolLLLaia Llucià-Carol
- Cristina Gallego-FabregaCGCristina Gallego-Fabrega
- Natalia CullellNCNatalia Cullell
- Miquel LledósMLMiquel Lledós
- José CastilloJCJosé Castillo
- Tomás SobrinoTomás Sobrino
- Francisco CamposFrancisco Campos
- Emilio Rodríguez-CastroEREmilio Rodríguez-Castro
- Mònica MillánMMMònica Millán
Open Access
- 16 July 2021
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (14) , 3137
Abstract
Stroke is one of the most common causes of death and disability. Reperfusion therapies are the only treatment available during the acute phase of stroke. Due to recent clinical trials, these therapies may increase their frequency of use by extending the time-window administration, which may lead to an increase in complications such as hemorrhagic transformation, with parenchymal hematoma (PH) being the more severe subtype, associated with higher mortality and disability rates. Our aim was to find genetic risk factors associated with PH, as that could provide molecular targets/pathways for their prevention/treatment and study its genetic correlations to find traits sharing genetic background. We performed a GWAS and meta-analysis, following standard quality controls and association analysis (fastGWAS), adjusting age, NIHSS, and principal components. FUMA was used to annotate, prioritize, visualize, and interpret the meta-analysis results. The total number of patients in the meta-analysis was 2034 (216 cases and 1818 controls). We found rs79770152 having a genome-wide significant association (beta 0.09, p-value 3.90 × 10−8) located in the RP11-362K2.2:RP11-767I20.1 gene and a suggestive variant (rs13297983: beta 0.07, p-value 6.10 × 10−8) located in PCSK5 associated with PH occurrence. The genetic correlation showed a shared genetic background of PH with Alzheimer’s disease and white matter hyperintensities. In addition, genes containing the ten most significant associations have been related to aggregated amyloid-β, tau protein, white matter microstructure, inflammation, and matrix metalloproteinases.Keywords
Funding Information
- Instituto de Salud Carlos III (CM18/00198, CD20/00043, FI19/00309, CP12/03298, CPII17/00027, CPII19/00020)
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2020FI_B1 00157)
- European Social Fund Plus (2020FI_B1 00157)
- European Regional Development Fund (CD20/00043)
This publication has 48 references indexed in Scilit:
- Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetesNature Genetics, 2012
- Does dementia increase risk of thrombolysis?Neurology, 2011
- METAL: fast and efficient meta-analysis of genomewide association scansBioinformatics, 2010
- Variant on 9p21 strongly associates with coronary heart disease, but lacks association with common strokeEuropean Journal of Human Genetics, 2009
- Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 releaseJournal of Leukocyte Biology, 2008
- Matrix Metalloproteinase-9 Pretreatment Level Predicts Intracranial Hemorrhagic Complications After Thrombolysis in Human StrokeCirculation, 2003
- How can I deal with missing data in my study?Australian and New Zealand Journal of Public Health, 2001
- How can I deal with missing data in my study?Australian and New Zealand Journal of Public Health, 2001
- Hemorrhagic Transformation Within 36 Hours of a Cerebral InfarctStroke, 1999
- Myosin V in the brain: mutations lead to neurological defectsBrain Research Reviews, 1998